TY - JOUR
T1 - Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model
AU - Southwood, Louise L.
AU - Frisbie, David D.
AU - Kawcak, Chris E.
AU - Ghivizzani, Steven C.
AU - Evans, Chris H.
AU - McIlwraith, C. Wayne
N1 - Funding Information:
The research was funded by Morris Animal Foundation. The authors’ thank Heather Colhoun, Claire Miller, and the volunteers at the Equine Orthopaedic Research Laboratory CSU for their technical assistance; and Dr Richard Park for assisting with radiographic evaluation.
PY - 2004
Y1 - 2004
N2 - The objective of this study was to evaluate the use of adenoviral transfer of the BMP-2 gene (Ad-BMP-2) for enhancing healing in an infected defect fracture model. A femoral defect stabilized with plates and screws was surgically created in sixty-four skeletally mature New Zealand white rabbits. Experimental groups were: (1) non-infected Ad-luciferase (Ad-LUC, NONLUC), (2) non-infected Ad-BMP-2 (NONBMP), (3) infected Ad-LUC (INFLUC), and (4) infected Ad-BMP-2 (INFBMP). A sclerosing agent was applied to the ends of the bone at surgery to facilitate the development of osteomyelitis. Fracture healing was evaluated radiographically and histologically. Data were analyzed using an ANOVA, with statistical significance set as p < 0.05. Rabbits in the non-infected and infected groups that were treated, with Ad-BMP-2 had earlier initial- and bridging-callus formation, and a higher overall external callus grade compared to rabbits in the Ad-LUC groups. Rabbits in the Ad-LUC groups had more defect ossification compared to rabbits in the Ad-BMP-2 groups. There was a trend for rabbits in the Ad-BMP-2 group that were euthanized at 2 and 4 weeks after surgery to have more bone and cartilage compared to rabbits in the Ad-LUC group. The results of this study suggest that Ad-BMP-2 enhances the early stages of healing in an infected defect fracture. The results of our study were not as favorable as those reported in previous studies because animals healed by a large bridging callus and not by defect ossification. This could have been a result of the sclerosing agent, which may have damaged the cells in the defect.
AB - The objective of this study was to evaluate the use of adenoviral transfer of the BMP-2 gene (Ad-BMP-2) for enhancing healing in an infected defect fracture model. A femoral defect stabilized with plates and screws was surgically created in sixty-four skeletally mature New Zealand white rabbits. Experimental groups were: (1) non-infected Ad-luciferase (Ad-LUC, NONLUC), (2) non-infected Ad-BMP-2 (NONBMP), (3) infected Ad-LUC (INFLUC), and (4) infected Ad-BMP-2 (INFBMP). A sclerosing agent was applied to the ends of the bone at surgery to facilitate the development of osteomyelitis. Fracture healing was evaluated radiographically and histologically. Data were analyzed using an ANOVA, with statistical significance set as p < 0.05. Rabbits in the non-infected and infected groups that were treated, with Ad-BMP-2 had earlier initial- and bridging-callus formation, and a higher overall external callus grade compared to rabbits in the Ad-LUC groups. Rabbits in the Ad-LUC groups had more defect ossification compared to rabbits in the Ad-BMP-2 groups. There was a trend for rabbits in the Ad-BMP-2 group that were euthanized at 2 and 4 weeks after surgery to have more bone and cartilage compared to rabbits in the Ad-LUC group. The results of this study suggest that Ad-BMP-2 enhances the early stages of healing in an infected defect fracture. The results of our study were not as favorable as those reported in previous studies because animals healed by a large bridging callus and not by defect ossification. This could have been a result of the sclerosing agent, which may have damaged the cells in the defect.
KW - Adenoviral vector
KW - BMP-2
KW - Gene therapy
KW - Infected defect fracture
KW - Osteomyelitis
UR - http://www.scopus.com/inward/record.url?scp=0347029878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347029878&partnerID=8YFLogxK
U2 - 10.1016/S0736-0266(03)00129-3
DO - 10.1016/S0736-0266(03)00129-3
M3 - Article
C2 - 14656661
AN - SCOPUS:0347029878
SN - 0736-0266
VL - 22
SP - 66
EP - 72
JO - Journal of Orthopaedic Research
JF - Journal of Orthopaedic Research
IS - 1
ER -